ISOLATION AND CHARACTERIZATION OF RELATED IMPURITY IN MILNACIPRAN HYDROCHLORIDE ACTIVE PHARMACEUTICAL INGREDIENT

被引:1
|
作者
Khatri, Deepak M. [1 ]
Mehta, Priti J. [1 ]
机构
[1] Nirma Univ, Inst Pharm, Dept Pharmaceut Anal, Ahmadabad 382481, Gujarat, India
关键词
characterization; FT-IR; identification; liquid chromatography; mass; NMR spectroscopy; unknown impurity; NORADRENALINE REUPTAKE INHIBITOR; LIQUID-CHROMATOGRAPHY; SEROTONIN; ANTIDEPRESSANT; METABOLITES; HPLC;
D O I
10.1080/10826076.2013.778632
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Milnacipran hydrochloride is an antidepressant drug, belonging to a class of selective serotonin re-uptake inhibitors. Unknown impurity in active pharmaceutical ingredient and pharmaceutical formulation of Milnacipran hydrochloride was found to be 0.08% and 0.12%, respectively, by peak area, with sensitive, isocratic RP-HPLC method. As per revised guidelines of International Conference on Harmonization Q3A (R2) and Q3B (R2), impurity profiling should be done for drug substances and drug products to identify and characterize all the unknown impurities that are present at level above 0.05%. This unknown impurity was targeted and isolated by developed Prep-HPLC method. The isolated impurity is characterized as 1-phenyl-3-azabicyclo [3.1.0] hexan-2-one using spectroscopic techniques like FT-IR, Mass, and NMR. The origin of the impurity is also postulated by proposing the plausible mechanism of formation.
引用
收藏
页码:1133 / 1144
页数:12
相关论文
共 50 条
  • [21] Stability-Indicating HPTLC Method for Determination of Milnacipran Hydrochloride in Pharmaceutical Formulations
    Deepak Mohanlal Khatri
    Priti Jignesh Mehta
    JPC – Journal of Planar Chromatography – Modern TLC, 2011, 24 : 412 - 418
  • [22] Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules
    D'Hondt, Matthias
    Wynendaele, Evelien
    Vandercruyssen, Kirsten
    Bauters, Tiene
    Vandenbroucke, Johan
    Mullens, Steven
    Vervaet, Chris
    Remon, Jean Paul
    De Spiegeleer, Bart
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 96 : 68 - 76
  • [23] Isolation and identification of a new impurity in mitoxantrone hydrochloride
    Ling Haiyan
    PHARMAZIE, 2009, 64 (06): : 376 - 379
  • [24] Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
    De Groot, Anne S.
    Cousens, Leslie
    Mingozzi, Federico
    Martin, William
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013, : 493138
  • [25] Proces Validation in Active Pharmaceutical Ingredient Synthesis
    Skuballa, Norbert
    PHARMAZEUTISCHE INDUSTRIE, 2012, 74 (08): : 1358 - +
  • [26] Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation
    Thomas, Saji
    Mathela, Chandra S.
    Agarwal, Ashutosh
    Paul, Saroj Kumar
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 56 (02) : 423 - 428
  • [27] Crystallization of an active pharmaceutical ingredient that oils out
    Lu, Jie
    Li, Yi-Ping
    Wang, Jing
    Ren, Guo-Bin
    Rohani, Sohrab
    Ching, Chi-Bun
    SEPARATION AND PURIFICATION TECHNOLOGY, 2012, 96 : 1 - 6
  • [28] Structure of the active pharmaceutical ingredient bismuth subsalicylate
    Erik Svensson Grape
    Victoria Rooth
    Mathias Nero
    Tom Willhammar
    A. Ken Inge
    Nature Communications, 13
  • [29] Diosgenin: an important natural pharmaceutical active ingredient
    Huang, Nannan
    Yu, Dan
    Wu, Junkai
    Du, Xiaowei
    FOOD SCIENCE AND TECHNOLOGY, 2022, 42
  • [30] Structure of the active pharmaceutical ingredient bismuth subsalicylate
    Grape, Erik Svensson
    Rooth, Victoria
    Nero, Mathias
    Willhammar, Tom
    Inge, A. Ken
    NATURE COMMUNICATIONS, 2022, 13 (01)